Top stocks in focus: Oil India, Voltas, Gufic Biosciences, Satin Creditcare, Glaxosmithkline Pharma

17 Mar 2022 , 07:50 AM

OIL India said subsidiary Numaligarh Refinery will invest Rs 6,555 crore for implementation of petrochemical project at Numaligarh, Assam. The board also approved formation of a joint venture company between Assam Gas Company (AGCL) and Oil India (OIL) for the three geographical areas offered by Petroleum and Natural Gas Regulatory Board [PNGRB].

Voltas will enter into a joint venture arrangement with Highly International (Hong Kong), a wholly owned subsidiary of Shanghai Highly (Group) Company.

Gufic Biosciences has incorporated a wholly owned subsidiary firm – Gufic UK, to expand its pharmaceutical business in United Kingdom.

Satin Creditcare Network board on March 22 will consider fund raising by issuance of NCD on private placement basis.

Glaxosmithkline Pharmaceuticals has completed the transaction for sale of its trademarks pertaining to ‘lodex’ and ‘Ostocalcium’ brands in India to GlaxoSmithKline Asia Private Limited.

Om Infra secured two prestigious contracts from Public Health Engineering Department, Region Churu (Rajasthan).

Indiabulls Housing Finance board on March 22 will consider raising of funds via bonds, in one or more tranches, on private placement basis.

BEML board on March 22 will consider an interim dividend for FY22 on equity shares, if any. The record date for payment of interim dividend is fixed as March 30.

Yasho Industries has received board approval for a capital expenditure of Rs 350 crore in Phase 1 for its greenfield project at Pakhajan (Dahej), Gujarat.

Coastal Corporation board on March 29 will consider a proposal to issue equity shares to the existing shareholders on rights basis.

Allcargo Logistics board has approved an interim dividend of Rs3 per share.